Comar West Coast Ribbon Cutting Celebration

Comar, a premier supplier of specialty packaging solutions and custom molded medical devices and assemblies, was joined by customers, state and city government officials, members of the local Chamber of Commerce, their engineering partners at InterTech and Justin W. Capp, and their construction partners at Whiting Turner to commemorate the completion of its Rancho 2.0 Project with a ribbon-cutting ceremony at 9595 Utica Rd, Rancho Cucamonga, CA. The dedication took place on Monday, August 9th at 5:30pm.

The project consolidates employees, equipment, and operations from Comar’s existing Rancho Cucamonga and Garden Grove, California plants into a new state-of-the-art facility to support the incredible growth of our current and future customers.

The new 230,000 sq. ft. facility houses Injection Molding, Injection Blow Molding, and Injection Stretch Blow Molding cells and will be ISO 13485 certified, cGMP compliant, and FDA registered. Comar has added 50,000 sq. ft. of ISO Class 8 clean rooms and white rooms (Controlled Not-Classified) to support the manufacturing of diagnostic consumables, medical devices and sub-assemblies.

The site also has a full-service design, development, and prototyping center to complement Comar’s current east coast and mid-west innovation and development hubs.
Mike Ruggieri, CEO at Comar, said, “The dedication of the new Rancho Cucamonga facility is an inflection point for our organization. We dreamed of bringing together all our west coast capabilities under one roof and elevating them to the highest standards achievable. We believe this team has accomplished that and then some. It is an exciting space and will be a source of immense pride for our employees. For our customers in the medical and healthcare space, the investment will only advance our ability to deliver solutions that help them enhance and extend lives!”
In the past 18 months, Comar has been undergoing a period of rapid expansion, increasing its operational footprint by over 40% as it opens new manufacturing plants in New Jersey, Wisconsin, and California.
Visit us at MD&M West Expo / August 10-12, 2021 / Anaheim Convention Center / Anaheim, CA / Booth #1555

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.